Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 25, 2012

NIH Won’t Survive FY 2013 Without Budget Reduction, GEN Poll Predicts

  • NIH won’t get through the next fiscal year without budget cuts of some sort, believe a clear majority of voters on a recent GEN poll. NIH and other agencies could see their spending curbed in FY 2013 and beyond, according to 71.4% of respondents, while 10.7% expect a budget increase, and a larger-than-usual 17.9% were undecided.

    Those expecting budget cuts are no doubt reacting to the both the unfinished effort to cut at least $1.2 trillion over the next decade and the election results, which could embolden spending-cutters. NIH dodged a bullet last month when Congress approved a 1% increase to its funding compared to fiscal year 2011. NIH will have $30.6 billion for FY 2012, while in FY ’11 the agency saw its funding cut by nearly 1% from the previous federal fiscal year.


Readers' Comments

Posted 03/09/2012 by kat.sbir

Cuts highly unlikely.  No increase more probable.


Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »